These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
801 related articles for article (PubMed ID: 3110839)
1. The use of a plus-maze to measure anxiety in the mouse. Lister RG Psychopharmacology (Berl); 1987; 92(2):180-5. PubMed ID: 3110839 [TBL] [Abstract][Full Text] [Related]
2. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Pellow S; Chopin P; File SE; Briley M J Neurosci Methods; 1985 Aug; 14(3):149-67. PubMed ID: 2864480 [TBL] [Abstract][Full Text] [Related]
3. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Dawson GR; Crawford SP; Collinson N; Iversen SD; Tricklebank MD Psychopharmacology (Berl); 1995 Apr; 118(3):316-23. PubMed ID: 7617825 [TBL] [Abstract][Full Text] [Related]
4. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Holmes A; Rodgers RJ Neurosci Biobehav Rev; 1999 Nov; 23(7):971-80. PubMed ID: 10580311 [TBL] [Abstract][Full Text] [Related]
6. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? File SE; Zangrossi H Psychopharmacology (Berl); 1993; 110(1-2):240-4. PubMed ID: 7870892 [TBL] [Abstract][Full Text] [Related]
7. Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety. Lister RG Pharmacol Biochem Behav; 1988 Jul; 30(3):701-6. PubMed ID: 3211980 [TBL] [Abstract][Full Text] [Related]
8. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Weiss SM; Wadsworth G; Fletcher A; Dourish CT Neurosci Biobehav Rev; 1998; 23(2):265-71. PubMed ID: 9884119 [TBL] [Abstract][Full Text] [Related]
9. Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol. Lapin IP Pharmacol Biochem Behav; 1993 Jan; 44(1):241-3. PubMed ID: 8094251 [TBL] [Abstract][Full Text] [Related]
10. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Cruz AP; Frei F; Graeff FG Pharmacol Biochem Behav; 1994 Sep; 49(1):171-6. PubMed ID: 7816869 [TBL] [Abstract][Full Text] [Related]
11. A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat. Redfern WS; Williams A Br J Pharmacol; 1995 Oct; 116(3):2081-9. PubMed ID: 8640349 [TBL] [Abstract][Full Text] [Related]
12. The influence of open arm ledges and maze experience in the elevated plus-maze. Fernandes C; File SE Pharmacol Biochem Behav; 1996 May; 54(1):31-40. PubMed ID: 8728536 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. File SE; Mabbutt PS; Hitchcott PK Psychopharmacology (Berl); 1990; 102(1):98-101. PubMed ID: 1975449 [TBL] [Abstract][Full Text] [Related]
14. The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine. Silva RH; Frussa-Filho R J Neurosci Methods; 2000 Oct; 102(2):117-25. PubMed ID: 11040408 [TBL] [Abstract][Full Text] [Related]
15. The effects of pentylenetetrazol, chlordiazepoxide and caffeine in rats tested in the elevated plus-maze depend on the experimental illumination. Garcia AM; Cardenas FP; Morato S Behav Brain Res; 2011 Feb; 217(1):171-7. PubMed ID: 20933019 [TBL] [Abstract][Full Text] [Related]
16. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Rodgers RJ; Cole JC; Aboualfa K; Stephenson LH Pharmacol Biochem Behav; 1995 Dec; 52(4):805-13. PubMed ID: 8587923 [TBL] [Abstract][Full Text] [Related]
17. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat. Cole BJ; Hillmann M; Seidelmann D; Klewer M; Jones GH Psychopharmacology (Berl); 1995 Sep; 121(1):118-26. PubMed ID: 8539336 [TBL] [Abstract][Full Text] [Related]
18. Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest. Roy V; Chapillon P; Jeljeli M; Caston J; Belzung C Psychopharmacology (Berl); 2009 Mar; 203(1):131-41. PubMed ID: 18998112 [TBL] [Abstract][Full Text] [Related]
19. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Ouagazzal AM; Kenny PJ; File SE Psychopharmacology (Berl); 1999 May; 144(1):54-60. PubMed ID: 10379624 [TBL] [Abstract][Full Text] [Related]
20. Fetal ethanol effects on benzodiazepine sensitivity measured by behavior on the elevated plus-maze. Osborn JA; Yu C; Gabriel K; Weinberg J Pharmacol Biochem Behav; 1998 Jul; 60(3):625-33. PubMed ID: 9678645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]